申请人:Rejuvgen Pharmaceuticals, Inc.
公开号:EP3564215A1
公开(公告)日:2019-11-06
The present invention provides a polyhydroxyphthalazinone compound, preparation method thereof and use thereof, wherein the general formula of chemical structure of the polyhydroxyphthalazinone compound is shown by the formula (I). The polyhydroxyphthalazinone compound disclosed by the present invention has a good effect on activating ERβ receptor, and it is expected to develop a novel ER-β receptor agonist.
本发明提供了一种多羟基酞嗪酮化合物及其制备方法和用途,其中多羟基酞嗪酮化合物的化学结构通式如式(I)所示。本发明公开的多羟基酞嗪酮化合物具有良好的激活ERβ受体的作用,有望开发出一种新型的ER-β受体激动剂。